Omaha, NE – Streck, Inc. and HiSS Diagnostics GmbH, a medical laboratory product distributor in Germany, have signed a distribution agreement for Streck’s molecular and cell stabilization products.
Streck’s cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA (cfDNA) in urine; Cell-Free DNA BCT® CE, a direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of high-quality cell-free DNA for a wide range of downstream applications commonly used in clinical research studies, drug discovery and diagnostic assay development; and Cell-Free RNA BCT® CE, a blood collection tube with a patented preservative which stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage. The tubes are for Export Only. Not for sale in the U.S.
Streck’s molecular product line includes Streck Antibiotic Resistance Monitoring & Detection (ARM-D®) kits, PhilisaFAST® DNA Polymerase and Streck’s Real-Time PCR System, the Zulu RT™.
“As a provider of products for quality assurance and molecular analysis in the medical laboratory, our partnership with Streck will enable us to provide customers with the premium quality cell stabilization and molecular
“We are pleased to partner with a company that will allow Streck increased market penetration,” said Connie Ryan, President and CEO at Streck. “In addition, HiSS will be able to provide excellent local support to our German customers.”
HiSS Diagnostics was founded in 1989 in Freiburg, Germany. Initially, HiSS Diagnostics exclusively sold products of representative suppliers, mainly from the United States and Netherlands, for medical microbiology, immunology and quality assurance in the medical laboratory. Since 1991, the company’s offering has expanded to include a full range of antibodies for flow cytometry and hematology. Today, HiSS Diagnostics is also a trusted supplier of research and diagnostics products for next-generation sequencing, microarrays and qPCR in oncology and hematology and other applications, isolation and sequencing of cell-free DNA in liquid biopsy being one focus.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.